Vaccine Potential of theNeisseria meningitidis2086 Lipoprotein

Вакцинный потенциал липопротеина 2086 Neisseria meningitidis
Ying Zhang, Xiaoling Xie, Robert J. Zagursky, Alan P. Howell, Leah D. Fletcher, Liesel Bernfield, Vicki L. Barniak, John E. Farley, Melissa Knauf, Peggy Ooi, Robert P. Smith, Paige Weise, Mike Wetherell, Gary W. Zlotnick
2004-03-23

LP2086 lipoproteinLP2086 subfamiliesNeisseria meningitidiscross-reactive bactericidal antibodiesvaccine development
A novel antigen that induces cross-reactive bactericidal antibodies against a number of Neisseria meningitidis strains is described. This antigen, a approximately 28-kDa lipoprotein called LP2086, was first observed within a complex mixture of soluble outer membrane proteins (sOMPs) following a series of fractionation, protein purification, and proteomics steps. Approximately 95 different neisserial isolates tested positive by Western blotting and PCR screening methods for the presence of the protein and the gene encoding LP2086. The strains tested included isolates of N. meningitidis serogroups A, B, C, W135, and Y, Neisseria gonorrhoeae, and Neisseria lactamica. To better understand the microheterogeneity of this protein, the 2086 genes from 63 neisserial isolates were sequenced. Two different subfamilies of LP2086 were identified based on deduced amino acid sequence homology. A high degree of amino acid sequence similarity exists within each 2086 subfamily. The highest degree of genetic diversity was seen between the two subfamilies which share approximately 60 to 75% homology at the nucleic acid level. Flow cytometry (fluorescence-activated cell sorting) analyses and electron microscopy indicated that the LP2086 is localized on the outer surface of N. meningitidis. Antiserum produced against a single protein variant was capable of eliciting bactericidal activity against strains expressing different serosubtype antigens. Combining one recombinant lipidated 2086 (rLP2086) variant from each subfamily with two rPorA variants elicited bactericidal activity against all strains tested. The rLP2086 family of antigens are candidates worthy of further vaccine development.
1
A single LP2086 variant induced bactericidal activity against strains expressing different serosubtype antigens; combining variants from both subfamilies with two rPorA variants killed all tested strains.
2
Approximately 95 neisserial isolates, including serogroups A, B, C, W135, and Y, carried LP2086 protein and encoding genes.
3
Flow cytometry and electron microscopy localized LP2086 to the outer surface of N. meningitidis.
4
LP2086 is an approximately 28-kDa Neisseria lipoprotein that induces cross-reactive bactericidal antibodies against multiple N. meningitidis strains.
5
Sequencing of 63 isolates identified two LP2086 subfamilies with high within-subfamily similarity but approximately 60–75% nucleotide homology between subfamilies.

LP2086 lipoprotein antigens from Neisseria meningitidis and related Neisseria isolates

LP2086 antigen distribution, surface localization, sequence microheterogeneity, cross-reactive bactericidal immunogenicity, and potential as a broadly protective vaccine component

Publication Details
Publication Date
2004-03-23
Journal
Publisher
ISSN
Cited by
333
Access Type
Author Information
Authors
Ying Zhang
Xiaoling Xie
Robert J. Zagursky
Alan P. Howell
Leah D. Fletcher
Liesel Bernfield
Vicki L. Barniak
John E. Farley
Melissa Knauf
Peggy Ooi
Robert P. Smith
Paige Weise
Mike Wetherell
Gary W. Zlotnick
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%